       Document 0641
 DOCN  M9610641
 TI    Clinical considerations in vaccine trials with special reference to
       candidate HIV vaccines.
 DT    9601
 AU    Fast PE; Sawyer LA; Wescott SL; Vaccine and Prevention Research Program,
       National Institute of; Allergy and Infectious Diseases, National
       Institutes of Health,; Bethesda, Maryland 20892, USA.
 SO    Pharm Biotechnol. 1995;6:97-134. Unique Identifier : AIDSLINE
       MED/96057683
 DE    Animal  AIDS Vaccines/ADVERSE EFFECTS/*THERAPEUTIC USE  Clinical Trials
       Human  HIV Infections/IMMUNOLOGY/PREVENTION & CONTROL  HIV-1/*IMMUNOLOGY
       Outcome Assessment (Health Care)  Research Design  *Vaccines/ADVERSE
       EFFECTS  JOURNAL ARTICLE  REVIEW  REVIEW, ACADEMIC

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

